| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 72.49B | 70.52B | 69.23B | 65.45B | 58.76B | 52.15B |
| Gross Profit | 10.64B | 10.53B | 10.68B | 10.04B | 10.57B | 9.63B |
| EBITDA | 8.44B | 8.04B | 9.18B | 7.77B | 8.20B | 7.71B |
| Net Income | 5.00B | 5.01B | 4.23B | 3.79B | 4.25B | 4.21B |
Balance Sheet | ||||||
| Total Assets | 138.84B | 134.88B | 129.21B | 118.87B | 115.94B | 107.05B |
| Cash, Cash Equivalents and Short-Term Investments | 14.89B | 17.21B | 19.18B | 18.83B | 18.25B | 16.43B |
| Total Debt | 14.59B | 16.30B | 11.28B | 13.59B | 10.98B | 13.46B |
| Total Liabilities | 109.02B | 105.09B | 109.52B | 101.14B | 102.96B | 97.56B |
| Stockholders Equity | 26.12B | 26.09B | 19.61B | 17.70B | 12.95B | 9.47B |
Cash Flow | ||||||
| Free Cash Flow | 1.68B | 4.24B | 3.73B | 3.20B | 3.82B | 2.71B |
| Operating Cash Flow | 5.62B | 8.05B | 7.40B | 6.25B | 6.29B | 4.64B |
| Investing Cash Flow | -4.20B | -4.79B | -6.65B | -4.13B | -3.11B | -2.72B |
| Financing Cash Flow | -3.24B | -3.41B | -2.57B | -1.28B | -2.12B | -2.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $93.11B | 21.58 | 17.41% | 1.73% | 9.35% | 10.49% | |
68 Neutral | $302.49B | 38.03 | 46.39% | 0.48% | 21.75% | 26.48% | |
67 Neutral | $161.51B | 15.22 | 21.22% | 1.47% | 12.01% | 22.70% | |
67 Neutral | $237.11B | 31.57 | 11.23% | 1.44% | 10.56% | 56.63% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $119.43B | 23.12 | 74.53% | 2.77% | 4.59% | -10.76% | |
53 Neutral | $180.54B | -10,177.67 | -8719.23% | ― | 32.74% | ― |